The regulated release of anorexigenic a-melanocyte stimulating hormone (a-MSH) and orexigenic Agouti-related protein (AgRP) from discrete hypothalamic arcuate neurons onto common target sites in the central nervous system has a fundamental role in the regulation of energy homeostasis. Both peptides bind with high affinity to the melanocortin-4 receptor (MC4R); existing data show that a-MSH is an agonist that couples the receptor to the Ga s signalling pathway 1 , while AgRP binds competitively to block a-MSH binding 2 and blocks the constitutive activity mediated by the ligand-mimetic amino-terminal domain of the receptor 3 . Here we show that, in mice, regulation of firing activity of neurons from the paraventricular nucleus of the hypothalamus (PVN) by a-MSH and AgRP can be mediated independently of Ga s signalling by ligand-induced coupling of MC4R to closure of inwardly rectifying potassium channel, Kir7.1. Furthermore, AgRP is a biased agonist that hyperpolarizes neurons by binding to MC4R and opening Kir7.1, independently of its inhibition of a-MSH binding. Consequently, Kir7.1 signalling appears to be central to melanocortin-mediated regulation of energy homeostasis within the PVN. Coupling of MC4R to Kir7.1 may explain unusual aspects of the control of energy homeostasis by melanocortin signalling, including the gene dosage effect of MC4R 4 and the sustained effects of AgRP on food intake 5 .
The regulated release of anorexigenic a-melanocyte stimulating hormone (a-MSH) and orexigenic Agouti-related protein (AgRP) from discrete hypothalamic arcuate neurons onto common target sites in the central nervous system has a fundamental role in the regulation of energy homeostasis. Both peptides bind with high affinity to the melanocortin-4 receptor (MC4R); existing data show that a-MSH is an agonist that couples the receptor to the Ga s signalling pathway 1 , while AgRP binds competitively to block a-MSH binding 2 and blocks the constitutive activity mediated by the ligand-mimetic amino-terminal domain of the receptor 3 . Here we show that, in mice, regulation of firing activity of neurons from the paraventricular nucleus of the hypothalamus (PVN) by a-MSH and AgRP can be mediated independently of Ga s signalling by ligand-induced coupling of MC4R to closure of inwardly rectifying potassium channel, Kir7.1. Furthermore, AgRP is a biased agonist that hyperpolarizes neurons by binding to MC4R and opening Kir7.1, independently of its inhibition of a-MSH binding. Consequently, Kir7.1 signalling appears to be central to melanocortin-mediated regulation of energy homeostasis within the PVN. Coupling of MC4R to Kir7.1 may explain unusual aspects of the control of energy homeostasis by melanocortin signalling, including the gene dosage effect of MC4R 4 and the sustained effects of AgRP on food intake 5 .
To better understand the diametrically opposed regulation of food intake by a-MSH and AgRP, we sought to identify mechanism(s) by which these peptides control firing activity of MC4R neurons in the paraventricular nucleus of the hypothalamus (PVN), a brain nucleus in which MC4R is known to control food intake 6 . Using electrophysiology with murine hypothalamic slice preparations in which MC4R PVN neurons are labelled with green fluorescent protein (GFP), a-MSH increases the frequency of action potential firing in PVN MC4R neurons recorded from loose patches (Fig. 1a) , depolarizing these cells on average by ,8 mV through action on postsynaptic MC4R (Fig. 1b) 7 . a-MSH had no effect on neighbouring non-GFP-labelled neurons (Fig. 1c) . AgRP hyperpolarized PVN MC4R neurons (Fig. 1d ), inhibiting their firing activity.
We next examined if a-MSH depolarized neurons through activation of the Ga s -adenylyl cyclase-cAMP-PKA pathway. PKAi (20 mM intrapipette), a peptide inhibitor of PKA, failed to abolish the a-MSHinduced increase in firing frequency in PVN neurons during whole cell recording, (not shown) or to block a-MSH-induced depolarization of membrane potential (Fig. 1e) . Inhibition of adenylyl cyclase with SQ22536 (25 mM) similarly failed to block a-MSH-induced depolarization of membrane potential (Fig. 1f) . Finally, we examined whether blocking G protein signalling can inhibit MC4R-mediated depolarization by loading cells with the inhibitory GDP analogue, GDPbS. To verify that GDPbS blocked G-protein function, we examined effects of activation of D1 dopamine receptor, known to depolarize neurons via activation of Ga s . Activation of D1 dopamine receptor by the D1 agonist SKF83822 (5 mM) depolarized PVN neurons (Fig. 1g) . GDPbS (5 mM) blocked D1-mediated is G-protein independent. a, Normalized mean amplitude (6s.e.m.) and time-course of a-MSH action on firing frequencies of PVN MC4R neurons (n 5 14) recorded in loose-patch configuration using hypothalamic slice preparations from MC4R-GFP mice before and after the addition of 250 nM a-MSH and washout. b, A representative depolarizing response of a PVN MC4R neuron recorded in current clamp to bath application of 250 nM a-MSH. The bar graph represents mean 6 s.e.m. (***P , 0.001). V m , membrane potential in millivolts (mV). c, A representative response of a non-GFP-expressing PVN neuron recorded in current clamp to bath application of 250 nM a-MSH. Application of brief current pulses (lower trace) caused depolarization and burst firing (upper trace), while a-MSH failed to depolarize this neuron. The bar graph represents mean 6 s.e.m. (P . 0.1). d, A representative hyperpolarizing response of a PVN MC4R neuron recorded in current clamp to bath application of 100 nM AgRP. The bar graph represents mean 6 s.e.m. (**P , 0.01). e, Intracellular PKA inhibitor, PKAi (6-22 amide) at 20 mM, fails to block the a-MSH-induced depolarization of membrane potential in PVN MC4R neurons. f, Inhibition of adenylyl cyclase by SQ22536 fails to block depolarizing effects of a-MSH. g, Application of 5 mM SKF83822, a selective D1 receptor agonist, causes depolarization of PVN neurons (left panel). Intrapipette addition of 5 mM GDPbS, a blocker of G-protein signalling (right panel), fails to block the a-MSH-induced depolarization in PVN MC4R neurons, but blocks the depolarization and firing activity induced by SKF83822. Data in panels e, g show mean 6 s.e.m., *P , 0.05, ***P , 0.001, paired t-test. In all electrophysiological studies, each n represents an independent neuron and slice, and no more than two slices were used per animal.
or depolarization of PVN MC4R neurons by a-MSH (Extended Data Fig. 1a-d) , including GTPcS (a non-hydrolysable GTP analogue, 1.5 mM), gallein (a Gbc blocker, 25 mM), or U0126 (a MAPK inhibitor, 1 mM). Together, these findings support a novel hypothesis: a G-protein-independent pathway for MC4R-mediated depolarization of PVN neurons. The currents underlying MC4R mediated depolarization of PVN neurons were then characterized with current-voltage (I-V) analysis in external 20 mM K
1
. Using whole-cell recording from voltage clamped neurons pre-treated with 0.5 mM tetrodotoxin (TTX), 200 mM picrotoxin (PTX) and 1 mM kynurenic acid (KYN), current responses of PVN MC4R neurons to voltage ramps (2120 to 220 mV for 2 s) were used to generate the I-V relationships of the a-MSH-induced response (Fig. 2a-c) . a-MSH significantly (33%) decreased cell membrane conductance from 5.7 6 1.0 nS in control to 3.8 6 0.8 nS (Fig. 2g) , with current generated by a-MSH being linear from 2120 to 260 mV that rectified inwardly at membrane potentials negative to its reversal of polarity. Its reversal potential was near 248.1 6 3.4 mV in the presence of 20 mM external K (Fig. 2d-f) . Application of AgRP (50 nM) significantly increased membrane conductance (75%, Fig. 2g ), and the AgRP-activated current displayed a reversal of polarity (246.7 6 3.0 mV) and rectification properties similar to a-MSH, suggesting that AgRP increases the density of an inward rectifying K 1 current. A hallmark of Kir channel-mediated current is the relative blockade of K 1 outward current by intracellular polyamines and Mg 21 at membrane potentials positive to the ErevK 1 (ref. 9). To further characterize the MC4R-regulated current, we examined whether the amplitude of K 1 outward current affected by a-MSH is greater in Mg 21 depleted intracellular solution. Recordings from PVN neurons voltage clamped around 255 mV indicated that the amplitude of the a-MSH regulated current was approximately ten times greater when intracellular Mg 21 was depleted compared to control (Fig. 2h-j) . Another characteristic of Kir channels is sensitivity to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) 10 . While this response is attenuated in zero ATP internal solution in which phospholipid synthesis is blocked (Fig. 2k) , addition of 100 mM PtdIns (4,5)P 2 diC8 (1,2-dioctanoyl) to the internal solution potentiated the a-MSH-induced response. (Fig. 2k) .
To identify the subtype(s) of Kir channels involved in the a-MSHinduced depolarization, we used a panel of Kir channel blockers ( Fig. 2l and Supplementary Table 1) with previously characterized channel subtype specificity 11 . Additionally, we used the bee venom tertiapin Q, a blocker of Kir3.x and Kir1.1 and glibenclamide, a blocker of Kir6.x/SURx. The depolarizing effect of a-MSH was inhibited ,80% by 15 mM VU573, a selective blocker of Kir2.3, Kir3.x and Kir7.1, and blocked by the Kir7.1 blocker VU590, but not VUR5C, an inactive VU573 analogue, tertiapin Q, glibenclamide, or VU591. These data suggest that Kir7.1 generates the current underlying the a-MSH-induced depolarization in mouse PVN neurons. Kir7.1 is reported to be resistant to external BaCl 2 or CsCl, at concentrations that block other Kir channels
12
, and the a-MSH-induced depolarization persisted in the presence of BaCl 2 or CsCl. The increased amplitude of this response in higher concentrations of BaCl 2 (.1 mM) and CsCl (.2.5 mM), may result from non-selective blockade of other voltage-sensitive outward currents (Fig. 2m-o) . Additionally, Kir7.1 is more permeable to rubidium than other Kir(s) 13 , and when potassium gluconate in the patch pipette was replaced with RbCl (RbCl 130 mM and KCl 4 mM), a-MSH-induced, Rb-mediated depolarization was observed and its magnitude was significantly greater than physiological K 1 -mediated depolarization (Extended Data Fig. 2 ). Using dual fluorescence indicate that application of a-MSH and AgRP decrease and increase the cell membrane conductance, respectively, which rectifies inwardly at membrane potentials negative to its reversal of polarity that are near the estimated reversal potential of K 1 (a-MSH, n 5 14, b, c, g, AgRP, n 5 6, e-g). h-j, Depletion of intracellular Mg 21 significantly increases K 1 efflux through MC4R regulated channels at membrane potentials positive to the ErevK -depleted (j) internal solutions. k, While zero ATP pipette solution slightly attenuated depolarization amplitude, the addition of 100 mM PtdIns(4,5)P 2 diC8 to zero ATP solution significantly increased the amplitude of the a-MSH-induced depolarization recorded from PVN MC4R neurons. l, Effects of blockers of inward rectifying K 1 channels on a-MSH (250 nM)-induced depolarization of PVN MC4R neurons compared to a-MSH alone (control). m-o, Effects of various concentrations of BaCl 2 or CsCl on the a-MSH-induced depolarization measured in current clamp using similar protocol as in l. The a-MSH-induced depolarization was not blocked in higher concentrations of BaCl 2 (m, n) or CsCl (m, o), exhibiting a greater amplitude in the presence of these non-selective Kir blockers. Bars indicate mean 6 s.e.m., *P , 0.05, ***P , 0.001, unpaired t-test.
in situ hybridization in sections of mouse PVN, we also determined that approximately 90% of PVN neurons expressing MC4R messenger RNA co-expressed Kir7.1 mRNA (Extended Data Figs 3 and 4) .
To confirm that MC4R signalling is capable of modulating Kir7.1 function, we transfected MC4R and Kir7.1 channels into HEK293 cells, using an M125R variant of Kir7.1 that exhibits higher unitary conductance than the native channel, previously demonstrated to allow detection of the channel in cell lines 14 . Whole-cell recordings were performed 24-48 h after co-transfecting cells with MC4R, Kir7.1(M125R) and GFP expression plasmids to examine effects of a-MSH on membrane current by examining the I-V analysis of a-MSH response. a-MSH significantly decreased the amplitude (.50%) and slope of current responses, indicating closure of Kir7.1 channels (Fig. 3a-c 15 . The effect of receptor modulation on channel conductance can then be studied by subtracting flux intensity after experimental treatments from levels after vehicle. Using this system, dose-response analysis indicated that a-MSH mediates a MC4R-dependent closure of Kir7.1 channels with an half-maximal inhibitory concentration (IC 50 ) of 10 27.5 M (Fig. 3d, e) . Conversely, AgRP mediated a MC4R-dependent increase in Tl 1 flux through Kir7.1, with an EC 50 of 10 28.6 M (Fig. 3f, g ). AgRP did not appear to couple the MC4R to the cAMP inhibitory G protein, Ga i [response]max normalized a-c, Current responses of transfected HEK293 cells to voltage steps (a) and ramps (b) in control, 300 nM a-MSH, and washout. Bath application of a-MSH significantly reduced the amplitude (c) and slope of responses to voltage steps and ramps in a reversible manner (bar graph indicates mean 6 s.e.m.; *P , 0.05, ***P , 0.01, n 5 6, paired t-test). d-g, a-MSH reduces flux (IC 50 near 10 27.5 M, d and e) and AgRP increases flux (EC 50 near 10 28.6 M, h and i) through Kir7.1 channels in a concentration-dependent manner. Concentration-response curves in e and g are plotted using the maxima from data in d and f. h-k, Specificity of melanocortin receptor-Kir subunit coupling. h, a-MSH -induced decrease in Tl 1 flux in MC4R and MC1R expressing cells containing Kir7.1, but not in cells co-expressing Kir7.1 and the MC3R, or expressing Kir7.1 alone. i, a-MSH-induced decrease in Tl 1 flux via the MC4R is observed in cells transfected with Kir7.1, more weakly in cells expressing Kir4.1, and is not in cells expressing Kir2.1 or Kir2.3. j, VU573 (10 mM) blocks Tl 1 flux in MC4R1Kir7.1 transfected cells. k, VU573 does not block MC4R-Kir4.1-mediated Tl 1 flux in the transfected cell assay. l, m, Pre-incubation with 100 nM a-MSH of MC4R-glo expressing HEK293 cells directly depresses a cAMP test response to a second exposure to 100 nM a-MSH (l). RLU, relative light units. Pre-incubation MC4R-Kir7.1 HEK293 cells with 100 nM a-MSH directly increases the amplitude of the response of Kir7.1 to a second 100 nM a-MSH exposure (m). n, Kinetics of the normalized maximal cAMP (black) and Kir7.1 (red) response to a single dose of 100 nM a-MSH, calculated from l and m. In all Tl 1 flux and cAMP accumulation assays, coloured traces indicate mean and bars (black) indicate s.e.m. d-n, Panels show combined data from three or four (d and e only) independent experiments; points are means from the following number of wells. d, e, n 5 111; f, g, n 5 96; h, i, n 5 40-48; j, k, n 5 27-28; l, n 5 12; m, n 5 48.
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recruit b-arrestin to the receptor (Extended Data Fig. 6a-c) . These data support a G-protein-independent mechanism for the MC4R-mediated regulation of Kir7.1 by AgRP as well. To examine the selectivity of coupling between melanocortin receptors and Kir7.1, we created stable HEK293 cells expressing Kir7.1(M125R) alone, or Kir7.1(M125R) plus MC1R, MC3R, or MC4R. a-MSH (100 nM) significantly decreased Tl 1 flux in Kir7.1 HEK293 cells expressing MC1R or MC4R, but not MC3R (Fig. 3h ). a-MSH (100 nM) significantly decreased Tl 1 flux in HEK293 cells transfected with MC4R plus Kir7.1 or Kir4.1, but not cells expressing Kir2.1 or Kir2.3 (Fig. 3i) . The Kir7.1-specific channel blocker VU573 blocked the a-MSH effects on Kir7.1 function in the HEK293 cells (Fig. 3j) , as in the slice (Fig. 2l ). However, VU573 had no effect on a-MSH inhibition of Kir4.1 in HEK293 cells (Fig. 3k) , suggesting the conductance regulated by a-MSH in MC4R PVN neurons primarily involves Kir7.1. PKA activity was also not required for a-MSH-induced closure of Kir7.1 in HEK293 cells (Extended Data Fig. 7a, b) , and we also observed a synergistic effect of a-MSH and cAMP on Kir7.1 closure, in this system (Extended Data Fig. 7a-d) .
G-protein-coupled signalling of the MC4R exhibits b-arrestin-mediated desensitization. Pre-treatment of MC4R 1 Kir7.1 expressing HEK293 cells with a-MSH reduced the subsequent magnitude of the G-proteinmediated cAMP response of these cells to a-MSH (Fig. 3l ). Supporting the argument that coupling of the MC4R to Kir7.1 is non-G-proteinmediated, the MC4R-dependent inhibition of Tl 1 flux through Kir7.1 was hypersensitized by prior treatment with a-MSH (Fig. 3m) . Thus, while the time course of acute effects of MC4R activation on Kir7.1 was rapid (Fig. 3a) , the long term effects on the cAMP and Kir7.1 signalling pathways were highly divergent (Fig. 3n) . While cAMP levels peak between 1-2 min after a-MSH treatment, inhibition of Tl 1 flux by a-MSH treatment continues to increase up to 45 min post-treatment. Low-dose AgRP treatment (1 nM) increased Tl 1 flux for up to 24 h (data not shown); the apparent reduction in Tl 1 flux after high-dose AgRP treatment (for example, Fig. 3f ) is probably owing to saturation of the fluorescent dye binding substrate.
Additional data support a role for Kir7.1 in regulation of food intake by MC4R in vivo. The AgRP analogue miniAgRP (AgRP 87-120, C105A ) retains normal affinity for MC4R, and potency in inhibition of MC4R coupling to Ga s (Fig. 4a ), yet exhibits 70% reduction in its ability to stimulate food intake in rats 5 . In parallel with loss of orexigenic activity, this peptide has lost its ability to couple MC4R to Kir7.1 (Fig. 4b) . Conversely, we have also identified an a-MSH analogue, MC4-NN2-0453 17 (Novo), that preferentially couples MC4R to Kir7.1 over Ga s in cell culture, and potently depolarizes PVN MC4R neurons (Fig. 4c-f ). MC4-NN2-0453 also exhibited biased actions at MC4R in vivo. In a cAMPmediated response, the peptide was unable to induce intestinal peptide YY (PYY) release in vivo 18 (Fig. 4g) , and is a partial agonist ex vivo (Extended Data Fig. 8 ). In contrast, the peptide potently inhibited food intake at doses equimolar to other a-MSH analogues (Fig. 4h) . Knockdown of Kir7.1 gene expression in wild-type and MC4R mutant larval zebrafish, but not Kir7.1 mutant jaguar zebrafish, produced a reduction in linear growth and upregulation of GHRH gene expression, responses reported previously for activation of the MC4R 19 , (Extended Data Fig. 9a-e) , further supporting the argument that Kir7.1 acts downstream of MC4R.
These data show the MC4R can depolarize or hyperpolarize hypothalamic PVN neurons in response to a-MSH or AgRP, respectively, through a novel G protein independent signalling pathway involving regulation of the activity of Kir7.1. While MC4R also is likely to couple to Ga s in most cells, cAMP/PKA-dependent activation of K ATP channels, producing a-MSH-induced hyperpolarization, has been demonstrated in MC4R neurons in the brainstem 20 . Thus, while Kir7.1 signalling appears to be essential for depolarization of PVN MC4R neurons by a-MSH, Ga s signalling and elevation of cAMP may be depolarizing or hyperpolarizing, depending on the cellular context (Extended Data  Fig. 10 ). . Interestingly, we also find that the MC1R couples to Kir7.1, suggesting that the induction of pheomelanin (yellow-red pigments) synthesis in mammals, may involve MC1R-Kir7.1 regulation by agouti 29 M; a-MSH EC 50 5 1.6 3 10 28 M). e, f, Application of Novo induced significant depolarization of membrane potential in PVN neurons. g, Intraperitoneal administration of LY stimulated PYY release from L cells in vivo via an MC4R-dependent pathway, while NOVO did not. Data show mean and s.e.m., ***P , 0.001. h, Novo is a potent inhibitor of cumulative food intake, following an overnight fast and administration of equimolar doses of compounds indicated (6.9 mg Novo or 3 mg LY per kg of mouse) Data show mean 6 s.e.m., *P , 0.05; **P , 0.01, **, *P , 0.001, by paired t-test (e), or one-way ANOVA with Bonferroni post-test (g, h). n 5 24 (a, b), 12 (c, d) or 6 (e, g, h). Data are representative of two (g, h), three (a-d) or six (e) independent experiments.
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G2015 Macmillan Publishers Limited. All rights reserved also provide a basis for understanding the persistent action of AgRP on food intake 5 , and the gene dosage effect of MC4R mutations 4 , not typically seen for GPCRs. Furthermore, the pronounced bias for coupling the MC4R to Kir7.1 of a-MSH analogue MC4-NN2-0453, shown to potently inhibit food intake in the absence of a pressor response, suggests that biased agonists of the MC4R may exhibit useful therapeutic properties.
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METHODS
Hypothalamic slice electrophysiology. MC4R-GFP mice, backcrossed onto the C57BL/6J background, were previously characterized by dual immunohistochemistry and in situ hybridization to validate that GFP-positive neurons in the PVN expressed MC4R RNA
27
. Randomly selected MC4R-GFP male and female mice, 8-12 weeks of age, were deeply anaesthetized with isoflurane before decapitation. The brain was entirely removed and immediately submerged in ice-cold, gassed (95% O 2 , 5% CO 2 ) artificial cerebrospinal fluid (aCSF), containing (in mM): 126.2 NaCl, 3.1 KCl, 2 CaCl 2 , 1 MgCl 2 , 1 NaH 2 PO 4 , 26.2 NaHCO 3 , 10 glucose and 11 sucrose (320 mosm per kg, pH 7.39 when gassed with 95% O 2 , 5% CO 2 at room temperature). Brain blocks of containing hypothalamus were made by trimming the whole brains while immersed in oxygenated, near-freezing aCSF and glued to a dental-cement cast customized to the size of the block mounted on a plate with adjustable angle. Brain slices of 200-mm thicknesses were then cut at angle range between 44u and 49u in reference to horizontal plane and transferred to a glass beaker containing oxygenated ACSF at 31 uC. After an incubation period lasting at least one hour, a slice was transferred to a recording chamber (,2.0 ml in volume), then submerged and immobilized with nylon strands drawn taut across a C-shaped platinum wire (1 mm outer diameter), and perfused with warmed (31-32 uC) oxygenated ACSF at a rate of 2-3 ml min 21 . EGFP-fluorescent neurons were unambiguously identified and patched using combined epifluorescence and IR-DIC optics. Fluorescent neurons of healthy IR-DIC appearance but of every level of fluorescence brightness were chosen for electrophysiological recordings.
Drugs were either added to aCSF and bath applied to the slice via the perfusion system (for extracellular applications) or to the pipette solution to perform whole cell recordings (for intracellular applications). The small volume of the recording chamber relative to the flow rate assured a complete exchange of solution occurring in less than 1 min. The persisting effects of a peptide were therefore due to prolonged effects rather than a slow wash out.
In this study, whole-cell patch-clamp recordings were used to obtain information about action potential firing activity, and membrane potentials and currents. Unless stated otherwise, whole cell recordings were performed using patch pipettes of 3.4 MV to 5 MV resistance when filled with a solution containing (in mM); 125 K gluconate, 8 KCl, 4 MgCl 2 , 10 HEPES, 5 NaOH, 4 Na 2 ATP, 0.4 Na 3 GTP, 5 Na 2 -creatine phosphate, 7 sucrose and 7 KOH which resulted in a pH ,7.23 and osmolality of 295-300 mosmol per kg. The permeability of the a-MSH regulated channels were investigated by replacing K gluconate and KCl with 130 RbCl and 4 KCl, but otherwise similar condition. The examination of effects of Mg Neuronal integrity was assessed by all of the following: small holding current (#30 pA at 270 mV) when voltage-clamped, large amplitude rebound spikes, the ability to fire and lack of obvious morphological deterioration (that is, lack of blebbing and nucleus not visually present).
In order to quantify the action potential firing and amplitude of depolarization induced by a-MSH, current clamp recordings were performed in continuous mode while the membrane potential of neurons were held between 255 and 260 mV to prevent continuous spontaneous action potential firing. Effects of AgRP were measured while cells were held around 250 mV to allow neurons to fire action potentials spontaneously. The firing frequency and membrane potential of neurons was measured during a 3-min period before the application of the peptides, and for another 3-min period 7-11 min after administration of peptide, and results compared.
Voltage-clamp recordings in episodic mode were used to study I-V relationships of the a-MSH and AgRP responses. The series resistance was not compensated but was monitored during voltage clamp experiments. Trials were excluded if the series resistance changed more than 10-15 MV during episodic voltage-clamp recordings. To characterize the currents generated by peptides, we compared the I-V relationships of the TTX pre-treated PVN neurons obtained in control with that in the presence of bath-applied peptide and wash. Individual I-V relationships were established by analysing the current responses of each cell to a depolarizing voltage ramps of 2 s duration applied from hyperpolarized potentials. This protocol was repeated at regular intervals in control media, in the presence of a peptide, and after 10-15 min of washout of the peptide. Current and voltage traces from between 3-4 successive trials in control conditions were then digitally averaged offline and were compared with similarly averaged traces from an identical number of trials obtained after wash out. The values of the averaged current responses elicited under each condition were then plotted as a function of the corresponding values during voltage ramps to obtain individual I-V relationships.
Data were acquired at 10 kHz using a MultiClamp 700A amplifier (2,0003 gain, -3 dB filter frequency 5 kHz) and Clampex 10.0.1 software (Axon Instruments, Union City, CA). GraphPad Prism 5.0 (Graphpad Software, Inc., San Diego, CA) and Excel 2010 (Microsoft) were used for data analysis. Statistical tests used included the paired t-test, when examining response of the same neurons before and after treatment with a compound, and the unpaired t-test when comparing the responses of different sets of neurons. All studies were approved by the animal care and use committee of Vanderbilt University. Thallium assay. HEK293 cells (ATCC, tested mycoplasma negative) stably expressing human MC4R and Kir7.1(M125R), or other human receptors (MC1R, MC3R) or channels (Kir2.1, Kir2.3, Kir4.1) as indicated, were grown in MEM medium with 10% FBS without antibiotics, suspended in 20 ml of medium plus 1 mg ml 21 tetracycline, used to induce expression of the transfected tet-sensitive Kir7.1 gene, and plated in 384-well poly-D-lysine coated optical bottom plates (BD Biosciences) at 20,000 cells per well. Plates were incubated overnight for 22-24 h in the cell incubator at 37 uC, 5% CO 2 . The following day, each individual cell plate was washed and replaced with 20 ml assay buffer (Hank's balanced salt solution with HEPES). A thallium-sensitive dye, Thallos (TEFLabs), was diluted with assay buffer to 0.9 ng ml 21 , and 20 ml was loaded into each well. Cell plates were kept in the dark for 1 h at room temperature and then washed again with assay buffer to remove residual extracellular dye. Cell plates were then incubated with peptides, drugs and/or controls as indicated for 25 min (unless indicated otherwise). Thallium (10 ml of a 0.48 mM stock in assay buffer) was then loaded and fluorescence generated by thallium influx was recorded for up to 15 min, as indicated, using a Hammamatsu FDSS plate reader. Zebrafish. Wild-type Tab 14 or AB strain zebrafish were raised and bred at 26-28 uC, with 14 h light/10 h dark cycle. All zebrafish studies were conducted in larvae unselected with regard to gender. Larval stage was determined according to ref.
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2/2 mutant strain was obtained from the Sanger Institute Zebrafish Mutation Project; the jaguar (G157E) mutant was kindly provided by D. M. Parichy. All studies were approved by the animal care and use committee of Vanderbilt University. b-arrestin recruitment assays. b-arrestin recruitment was measured using PathHunter hMC4R cells (DiscoverX; Fremont, CA) stably expressing pro-link attached b-arrestin proteins according to the manufacturer's protocol. Cells were plated in 384-well plates at 5,000 cells per well. The following day, cells were treated with drug and incubated at 37 uC for 90 min. Substrate was added to each well and luminescence values were obtained after 60 min at room temperature using a Spectromax plate reader (Molecular Devices; Sunnydale, CA). Morpholino oligonucleotide injection, and body length measurement. Morpholino oligonucleotides, described below, were dissolved in nuclease-free water and stored in 220 uC as 1 mM stock. Serial dilutions were made using nucleasefree water to 0.01, 0.05, 0.1, 0.2, 0.3, and 0.4 mM working solution with 20% Phenol Red (Sigma; 0.5% in DPBS, sterile filtered, endotoxin tested). Before the injection, Morpholino oligonucleotides were denatured at 65 uC for 5 min and quickly spun to avoid the formation of aggregates. Three to five microlitres was loaded in a microinjection machine, and embryos at one or two cell stages were injected with 1-2 nl of a solution containing antisense targeting morpholino or standard control oligo. Each MO oligo injection was repeated at least three times, and doses were adjusted to optimize the phenotype-to-toxicity ratio. Following morpholino injections, embryos were raised in egg water, changed daily, under standard light/dark cycle up to 6 days post-fertilization (dpf). Dead embryos were excluded at 1 dpf. Embryos were assayed for quantitative RT-PCR of GHRH at 5 dpf. Linear body length (forehead to tail fin) was determined using a micrometre at 5 dpf. Embryos were mounted in 2.5% methyl cellulose, and images were taken by AxionVision (Ver3.1) software with a Lumar V12 Stereo Microscope (Carl Zeiss). Quantitative PCR. Embryos were homogenized in lysis buffer with a sonic dismembrator (model 100, Fisher Scientific, Pittsburgh, PA). Total RNA was extracted using an RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. To remove genomic DNA, On-Column DNase Digestion was performed using an RNase-Free DNase Set (Qiagen). One microgram of purified total RNA was reverse transcribed with iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). qPCR primers were designed by Beacon Designer 7.0 (Premier Biosoft International, Palo Alto, CA) to minimize primer self-dimerization, and primer sequences are indicated below. qPCRs were performed using 2 ml cDNA (20 ng) as template, 5 pmol of each of forward and reverse primers, and 23 Power SYBR PCR mix (Applied Biosystems, Carlsbad, CA) with nuclease free water (Promega, Madison, WI) to make the final volume to 20 ml in a 96-well plate (Bioexpress, Kaysville, UT). qPCRs were performed using an Mx3000PTM (Stratagene, Santa Clara, CA). The PCR cycle was performed according to manufacturer's instructions with initial denaturation at 95 uC for 10 min, followed by 45 cycles of 95 uC 20 s, 60 uC, 60 s. At the end of the cycles, melting curves of the products were verified for the specificity of PCR products. A standard curve with serial dilutions of cDNA sample was performed LETTER RESEARCH on each plate. All measurements were performed in duplicate, and Graph Pad Prism 5.0 was used for the interpretation and analysis of data. Morpholino and qPCR oligonucleotides. Antisense morpholino oligonucleotide (MO) against the ATG translation initiation site of agrp, kcnj13 and standard control MO were designed and synthesized by GeneTools, LLC (Philomath, OR USA). For morpholino injection agrp ATG MO: 59-TTTCAGCACCGCCGTCGTCATT TTC-39 Zebrafish Standard Control MO: 59-CCTCTTACCTCAGTTACAATTTATA-39 kcnj13 MO targeting intron-exon boundary:59-CAAATGCACCTGATGGGCAG AGAAA-39 For qPCR: ghrh (growth hormone releasing hormone), forward primer 59-GTGC TATGCTGCTTGTTACTATC-39, reverse primer 59-ATACTTGACTGACGCT TTACATTG-39. ef1a (Elongation Factor 1 alpha), with forward primer 59-CTGGAGGCCAGCTCA AACAT-39, reverse primer 59-ATCAAGAAGAGTAGTACCGCTAGCATTAC-39. MC4R-mediated PYY release assay. Male C57BL/6J mice were ordered from The Jackson Laboratory (Bar Harbour, ME). Experiments were run when the mice reached 12 weeks of age. On the day of study, the mice were fasted during the daytime for 4 h to reduce plasma PYY levels to baseline. Following the fast, mice were randomly selected to receive an intraperitoneal injection of saline (vehicle), 3 mg per kg of the a-MSH agonist LY2112688 (LY), or an equimolar dose of 6.9 mg per kg of MC4-NN2-0453 (NOVO). MC4-NN2-0453 corresponds to the previously reported peptide 19
17
. Numbers for each test were chosen based on prior experience suggesting significance could be achieved with as few as 6 animals per condition. At 10 min post-injection, the mice were quickly bled via the submandibular vein to obtain approximately 200 ml of whole blood. The blood was collected into vials containing EDTA and protease inhibitor cocktail for mammalian tissues (Sigma-Aldrich P8340) to prevent degradation of PYY. The vials containing whole blood were spun for 15 min at 1,500g at 4 uC to isolate the plasma. The plasma was stored at 280 uC until PYY levels were assayed. PYY was assayed in duplicate using the Milliplex magnetic bead based mouse metabolic hormone panel (Millipore MMHMAG-44K, 1-plex kit for total PYY). Results were analysed against a standard curve and concentrations were determined using Milliplex Analyst 5.1 software. Results were plotted and analysed using Graphpad Prism. All animal care and experimental procedures were approved by Vanderbilt University Medical Center Institutional Animal Care and Use Committee. Food intake analysis. 18 wild-type male C57BL6 were obtained from Jackson Laboratory. Upon arrival, mice were single-housed and allowed to acclimatize at 22 uC-24 uC with a 12-h light/12-h dark cycle with standard chow and water provided ad libitum for one week. For 5 days after the environment acclimation, mice were handled during the light cycle and given subcutaneous injections of 100 ml of saline to get them accustomed to being handled. During this time, daily food intake was also measured to establish a baseline. Mice were food deprived for 16 h before drug treatment, starting shortly before the beginning of the dark cycle on the fifth day. Experiments were blinded; drug compounds were prepared and coded the morning of the injections by an individual who would not be conducting the experiment. The randomly selected experimental groups were as follows: 6 animals were given vehicle (100 ml of saline), 6 animals were given 100 ml of 3.0 mg per kg LY2112688 (LY), and 6 animals were given and equimolar dose of MC4-NN2-0453 (NOVO; 100 ml of 6.9 mg per kg) subcutaneously. Numbers needed to achieve significant inhibition of food intake by a melanocortin compound versus saline were based on prior experience. Food intake was measured at 2 h, 4 h, 14 h, and 24 h after injection. The data was collected and analysed using GraphPad Prism. Statistical significance was established using one-way ANOVA and Bonferonni post-hoc with a P , 0.05 significance value. All animal care and experimental procedures were approved by Vanderbilt University Medical Center Institutional Animal Care and Use Committee. Coimmunoprecipitation and western blotting. HEK293T cells were plated in six-well plates and transfected with indicated plasmids 24 h before the experiment. Cells were rinsed once with PBS and proteins were crosslinked with 0.5 mM dithiobismaleimidoethane (DTME) in PBS for 30 min at room temperature. Crosslinking solution was removed and remaining crosslinker was quenched using a quenching solution (20 mM Tris-HCl pH 7.4, 5 mM L-cysteine) for 10 min at room temperature. Cells were lysed in 0.1% N-dodecyl-b-maltoside in PBS with protease inhibitors for 20 min, lysates were spun at 10,000 r.p.m. for 10 min and supernatants were transferred to new tubes. Lysates were incubated with indicated antibody (M2 anti-flag, Sigma F3165; anti-HA monoclonal antibody, Vanderbilt Antibody and Protein Resource, 12CA5) at 1:5,000 with rotation for 1 h at room temperature. Antibodies were pulled down using protein-G coated magnetic beads (Dynabeads, Life Technologies). Beads were washed 3 times with lysis buffer and proteins were eluted and crosslinking reversed with sample buffer containing 100 mM DTT. Samples were separated by SDS-PAGE and membranes blotted using M2 anti-Flag 1:5,000. Blots were revealed by ECL and film scanned. Densitometry analysis was done using Adobe Photoshop. n 5 2. Mucosal electrophysiology. Male C57BL/6J mouse descending colon mucosa devoid of overlying muscle was cut into 6 adjacent pieces and each placed between the two halves of an Ussing chamber (aperture 0.14 cm 2 ) and bathed in oxygenated Krebs-Henseleit (KH) buffer (in mM: 117 NaCl, 24.8 NaHCO 3 , 4.7 KCl, 1.2 MgSO 4 , 1.2 KH 2 PO 4 , 2.5 CaCl 2 and 11.1 D-glucose), 5 ml on both sides. Mucosae were voltage-clamped at 0 mV and the resultant vectorial ion transport measured as shortcircuit current (I sc ) as described previously 29 . After a 15 min equilibration period, vasoactive intestinal peptide (VIP, 10 nM) was added to stimulate epithelial anion secretion and 5-10 min later (once the VIP maximum had been achieved) a single concentration of either MC4-NN2-0453 (3 nM-3 mM) or a-MSH (300 nM) was administered. Consequent MC4R mediated reductions in I sc were measured for 20 min before a control concentration of PYY (10 nM) was added to reduce I sc levels via epithelial Y 1 receptors 29 . All additions were basolateral and changes in I sc were converted to mA cm 2 . MC4R activity and individual peptide responses were pooled and analysed using Graphpad Prism (version 5). All animal care and experimental procedures were approved by the King's College London Ethical Review Process Committee. Fluorescent in situ hybridization for MC4R and Kir7.1 mRNA. Various mRNA species expressed by PVN neurons were visualized with a variation of FISH (fluorescent in situ hybridization) called RNAscope (ACD; Advanced Cell Diagnostics, Inc., Hayward, CA). RNAscope cDNA probes and detection kits were purchased from ACD and used according to the company's online protocols. The probe sets directed against MC4R and Kir7.1 mRNA were designed from sequence information from the mouse RefSeq mRNA IDs NM_016977 and NM_001110277, respectively.
Four wild type male MC4-GFP littermates were euthanized with an overdose of Nembutal (100 mg per kg, intraperitoneally) and brains were quickly removed and frozen in powdered dry ice. Brains from three MC4R knockout mice 4 were prepared the same way. All brains were stored at 280 uC until cut on a cryostat (Leica CM3000). 16-mm sections were adhered to warm Fisher plus slides (Fisher Scientific) and immediately refrozen. Slides were stored at 280 uC until fixed with icecold 4% paraformaldehyde according to the ACD protocol for fresh frozen tissue. After fixation for 15 min, slides were dehydrated in an ethanol dilution series (50%, 70%, 100% 32). Slides were then air-dried for 5 min and a hydrophobic barrier was drawn around each section with an Immedge barrier pen. Sections were then incubated with ACD's pretreatment 4 solution for 30 min at room temperature in a humidified chamber. After pretreatment, sections were incubated with RNAscope probes and a series of signal amplification steps according to the ACD protocol for the Fluorescent Multiplex Kit. In brief, incubation steps included: probe mixtures at kit recommended dilutions for the C1 channel (blank or probes for ubiquitin C mRNA), the C2 channel (MC4R mRNA) and the C3 channel (Kir7.1 mRNA) for 2 h at 40 uC, wash twice, AMP-1 FL reagent for 30 min at 40 uC, wash twice, AMP-2 FL reagent for 15 min at 40 uC, wash twice, AMP-3 FL reagent for 30 min at 40 uC, wash twice, AMP-4 FL alt A or B reagent for 15 min at 40 uC, wash twice, DAPI reagent for 1-2 min at room temperature, remove standing liquid and immediately cover slip with either SlowFade Gold (Molecular Probes) or Aqua-Polymount (PolySciences, Inc.). 40 uC incubations were carried out in a HybEZ oven (ACD). Each run of 5 to 10 slides included one positive control (3 probe sets to house-keeping gene mRNA, ACD) and one negative control (3 probe sets for bacterial mRNA, ACD). Sections were imaged with a Zeiss 710 scanning confocal microscope using either a LD C-Apochromat 340/1.1 water lens or a Plan-Apochromat 363/1.40 oil lens. Z stacks were done on all sections using pin hole settings that resulted in 1.0-mm thick optical sections. Images were opened in Imaris (version 7.6), background subtracted and then contrast enhanced by increasing gamma to 1.5 to 2.3, then exported in tiff format for counting mRNA signals and labelled cells. Numbers of round, fraction delimited spots over and surrounding DAPI-labelled nuclei were manually counted with the aid of Metamorph software. Borders between cells were resolved with the help of grey scale DIC images overlaid on maximum intensity projections of the Z stacks. Negative control sections were used to count fluorescent dots that represented auto-fluorescent signals plus non-specific labelling by the multiplex kit. Sections of WT PVN hybridized with probes against bacterial mRNA were used to count background dots in the KIR7.1 channel and sections from MC4R knockout mice hybridized with the probes against MC4R mRNA were used to count background dots in the MC4R channel. The average number of dots per cell for the MC4R and Kir7.1 negative controls were 1.60 6 0.87 standard deviations and 1.31 6 0.70, respectively (354 cells from 6 sections for MC4R and 54 cells from 2 sections for Kir7.1; see supplementary figure). For cell counts in PVN sections from wild-type mice, cells were counted as positively labelled for MC4R and/or Kir7.1 mRNA if the number of dots per cell exceeded the mean plus RESEARCH LETTER 33 standard deviations of their respective negative controls (5 or more dots for MC4R and 4 or more dots for Kir7.1). Two of the images from wild-type mice were also analysed by an automated cell counting multiplex FISH module from Indica Labs, Inc. (Ahmedabad, India). The automated cell counts agreed with our manual count data with .90% of all MC4R mRNA positive cells also positive for Kir7.1 mRNA in the PVN. All animal care and experimental procedures were approved by Vanderbilt University Medical Center Institutional Animal Care and Use Committee.
27. Liu, H. et al. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J. Neurosci. 23, 7143-7154 (2003 
LETTER RESEARCH
Extended Data Figure 1 | G protein signalling is not required for a-MSHinduced depolarization of PVN MC4R neurons. a, b, A MAP kinase kinase inhibitor, 1 mM U0126, fails to block a-MSH -induced increase in firing frequency of PVN MC4R neurons recorded in whole cell configuration, (a, left panel shows a representative trace from one neuron, b, right panel shows mean 6 s.e.m. of firing frequency, *P , 0.05, paired t-test). c, GTPcS, a nonhydrolysable GTP analogue, fails to block the depolarization induced by a-MSH, measured in whole-cell configuration. This drug however does block the hyperpolarization induced by m-opioid agonist, DAMGO (10 mM), (mean 6 s.e.m., ***P , 0.001, paired t-test). d, The Gbc inhibitor gallein fails to inhibit a-MSH-induced depolarization of PVN MC4R neurons (mean 6 s.e.m., **P , 0.01, paired t-test), although it blocks the effects of DAMGO (10 mM) on membrane potential. In all electrophysiological studies, each n represents an independent neuron and slice, and no more than two slices were used per animal. 
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Extended Data Figure 9 | Effects of Kir7.1 and MC4R signalling in larval zebrafish. a-c, Knock-down of the Kir7.1 gene by kcnj13 morpholino oligonucleotide (MO) suppresses the axial growth of larvae in wild-type and mc4r null zebrafish. Sibling wild-type or mc4r-null zygotes were bred and injected with antisense kcnj13 morpholino oligonucleotide at day 0. a, The axial body length was measured at 5 dpf. Each group of 30 fish was harvested for RNA extraction and cDNA synthesis. b, Relative expression of ghrh mRNA was measured and normalized to the house keeping gene ef1a with qRT-PCR. The wild type fish that were injected with MO against kcnj13 expressed significantly higher copies of ghrh mRNA than those that were injected with control MO. (control MO, n 5 9, 1.056 6 0.116 vs kcnj13 MO, n 5 9, 1.935 6 0.294, unpaired t-test, *P , 0.05). MC4R-null fish that were injected with kcnj13 MO have significantly higher GHRH expression than MC4R-null fish that were injected with control MO (control MO, n 5 9, 1.040 6 0.164 vs KCNJ MO, n 5 8, 2.395 6 0.461, one-way ANOVA, P , 0.05). c, Representative WT fish injected with kcnj13 MO vs control MO. d, e, jaguar wild-type and null mutant siblings were bred and injected with 7.5 ng nontargeting standard control or 7.5 ng antisense morpholino oligonucleotide targeting agrp or kcnj13. d, Knockdown of AgRP with agrp MO in the absence of Kir7.1 also reduces larval growth (mean 6 s.e.m., n 5 43, ***P , 0.001, unpaired t-test). e, The deletion of Kir7.1 in jaguar null blocks effects of KCNJ13 MO on MC4R-mediated inhibition of growth (mean 6 s.e.m., n 5 58, unpaired t-test). Data are representative of three independent experiments. Figure 10 | A model for a-MSH and AgRP signalling at PVN MC4R neurons. Data presented here supports a model in which MC4R may couple to both Ga s signalling and regulation of Kir7.1 activity in PVN MC4R neurons. a-MSH results in elevation of intracellular cAMP through activation of Ga s , and inhibition of K 1 efflux through Kir7.1, both of which are depolarizing. AgRP lowers the constitutive activity of the MC4R and blocks a-MSH binding, but data here show that AgRP also acts as an agonist to increase K 1 efflux through Kir7.1, producing a strong hyperpolarizing signal. The relative distribution and composition of the MC4R signalling complex in different subcellular compartments of PVN MC4R neurons has not been directly determined. Earlier models of a-MSH and AgRP action suggested competitive binding of these peptides to individual MC4R sites (orange box). Existing neuroanatomical data characterizing POMC and AgRP neuronal projections show that a-MSH may act independently of AgRP at many sites in the central nervous system, since AgRP immunoreactive fibres are only observed in a subset of MC4R-expressing nuclei containing POMCimmunoreactive fibres (right circle, for review see ref. 25). The ability of AgRP to act independently of a-MSH as a potent hyperpolarizing agonist, via regulation of Kir7.1, suggests the likely existence of independent AgRP sites of action (left circle). Recent reconstruction of electron microscopy images of the PVN in which POMC-and AgRP-containing synaptic vesicles have been specifically labelled with a genetically encoded marker provides preliminary anatomical support for this new model 26 . This study demonstrates that 52% of AgRP boutons in the PVN are not found in synapses, potentially supporting volume transmission of AgRP that may lead to competition with a-MSH at synaptic and/or non-synaptic sites. Additionally, the study found the vast majority of AgRP and POMC synaptic sites localized to different subcellular compartments of PVN neurons, supporting the independent action of both peptides. Synaptic release sites on soma were almost exclusively AgRPcontaining, while POMC release sites were concentrated on distal dendrites. Another MC4R signalling pathway, involving cAMP/PKA-dependent activation of K ATP channels and a-MSH-induced hyperpolarization, has been demonstrated in MC4R neurons in the dorsal motor nucleus of the vagus in the brainstem (bottom right) 21 . Thus, while Kir7.1 signalling appears to be essential for depolarization of PVN MC4R neurons by a-MSH, Ga s signalling and elevation of cAMP may be depolarizing or hyperpolarizing, depending on the cellular context.
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